Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines

被引:7
|
作者
Essogmo, Freddy Elad [1 ,2 ]
Zhilenkova, Angelina V. [1 ]
Tchawe, Yvan Sinclair Ngaha [1 ]
Owoicho, Abah Moses [1 ]
Rusanov, Alexander S. [1 ]
Boroda, Alexander [1 ]
Pirogova, Yuliya N. [1 ]
Sangadzhieva, Zaiana D. [1 ]
Sanikovich, Varvara D. [1 ]
Bagmet, Nikolay N. [3 ]
Sekacheva, Marina I. [1 ]
机构
[1] Sechenov Univ, Moscow State Med Univ 1, Inst Personalized Oncol, Ctr Digital Biodesign & Personalized Healthcare,Mi, Moscow 119991, Russia
[2] Cameroon Oncol Ctr COC, POB 1864, Douala, Cameroon
[3] Petrovsky Natl Res Ctr Surg, Moscow 119435, Russia
关键词
lung cancer; cytokines; therapy; immune system; anti-tumor; TGF-BETA; IMMUNOTHERAPY; ROLES; INTERLEUKIN-10; INFLAMMATION; IMMUNITY; BIOLOGY; CELLS;
D O I
10.3390/cancers15225383
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Lung cancer is currently the second leading cause of cancer death worldwide. Cytokines are small proteins that carry messages between cells and are known to play an important role in the body's response to inflammation and infection. Cytokines are important for immunity in lung cancer. The immune system relies heavily on cytokines which can also be produced in the laboratory for therapeutic use. Cytokine therapy helps the immune system to stop the growth or kill cancer cells including lung cancer cells. High doses of cytokines are required to induce a beneficial response in cancer patients, but doing so leads to many problems, including their short lifespan and toxicity. New technologies are being developed to help improve the targeting of cytokines and alter their side effects.Abstract Lung cancer is currently the second leading cause of cancer death worldwide. In recent years, checkpoint inhibitor immunotherapy (ICI) has emerged as a new treatment. A better understanding of the tumor microenvironment (TMJ) or the immune system surrounding the tumor is needed. Cytokines are small proteins that carry messages between cells and are known to play an important role in the body's response to inflammation and infection. Cytokines are important for immunity in lung cancer. They promote tumor growth (oncogenic cytokines) or inhibit tumor growth (anti-tumour cytokines) by controlling signaling pathways for growth, proliferation, metastasis, and apoptosis. The immune system relies heavily on cytokines. They can also be produced in the laboratory for therapeutic use. Cytokine therapy helps the immune system to stop the growth or kill cancer cells. Interleukins and interferons are the two types of cytokines used to treat cancer. This article begins by addressing the role of the TMJ and its components in lung cancer. This review also highlights the functions of various cytokines such as interleukins (IL), transforming growth factor (TGF), and tumor necrosis factor (TNF).
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Mechanisms for anti-tumor response to oncogenic RAS in normal human epithelial cells
    Otsubo, Kasumi
    Yugawa, Takashi
    Nakahara, Tomomi
    Kiyono, Tohru
    CANCER SCIENCE, 2018, 109 : 782 - 782
  • [32] Activin-A protects against lung cancer progression by potentiating anti-tumor immunity
    Morianos, I.
    Bostantzoglou, C.
    Gaga, M.
    Xanthou, G.
    Semitekolou, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1520 - 1520
  • [33] Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer
    Chen, Long Xia
    Ni, Xiao Ling
    Zhang, Heng
    Wu, Min
    Liu, Jing
    Xu, Shan
    Yang, Ling Lin
    Fu, Shao Zhi
    Wu, Jingbo
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 : 2463 - 2476
  • [34] Anti-tumor activity of a recombinant measles virus against canine lung cancer cells
    Tamura, Kei
    Fujiyuki, Tomoko
    Moritoh, Kanako
    Akimoto, Hayato
    Iizuka, Keigo
    Sato, Hiroki
    Asano, Kazushi
    Yoneda, Misako
    Kai, Chieko
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [35] Origin and anti-tumor effects of anti-dsDNA autoantibodies in cancer patients and tumor-bearing mice
    Lv, S
    Zhang, JP
    Wu, J
    Zheng, XJ
    Chu, YW
    Xiong, SD
    IMMUNOLOGY LETTERS, 2005, 99 (02) : 217 - 227
  • [36] IL-7 enhances the anti-tumor response in nonsmall cell lung cancer
    Yang, Seok Chul
    Kim, Young Whan
    You, Chul-Gyu
    Lee, San Min
    Lee, Choon-Taek
    Han, Sung Koo
    Shim, Young-Soo
    Lim, Jae-Jun
    Hillinger, Sven
    Zhu, Li
    Dubinett, Steven M.
    Sharma, Sherven
    CHEST, 2007, 132 (04) : 458S - 458S
  • [37] Role of CD38 in anti-tumor immunity of small cell lung cancer
    Taniguchi, Hirokazu
    Chavan, Shweta S.
    Chow, Andrew
    Chan, Joseph M.
    Mukae, Hiroshi
    Rudin, Charles M.
    Sen, Triparna
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] Tumor mutational burden profile (TMB) of oncogenic driver mutations in non small cell lung cancer
    Walker, Paul
    Sharma, Nitika
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [39] Cancer Stem Cells and Anti-tumor Immunity
    Yilmaz, Merve
    Kaplan, Fuat
    Mender, Ilgen
    Gryaznov, Sergei M.
    Dikmen, Z. Gunnur
    CURRENT STEM CELL RESEARCH & THERAPY, 2023, 18 (04) : 445 - 459
  • [40] Inflammasomes in Cancer Progression and Anti-Tumor Immunity
    Lillo, Sebastian
    Saleh, Maya
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10